Record quarterly revenue of $62.6 million Talend Cloud represented 49% of new ARR, up from 43% in the previous quarter REDWOOD CITY, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Talend (NASDAQ: TLND), a global leader in cloud data integration and data …
SAN JOSE, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- MoSys, Inc. (NASDAQ: MOSY), a provider of semiconductor solutions that enable fast, intelligent data access for cloud networking, security, test and video systems, today reported financial results for the …
Company Provides Key Updates on Tau Pipeline Candidates LAUSANNE, Switzerland, Nov. 06, 2019 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative …
Third Quarter 2019 Net Loss of $25.2 million -- $0.83 per diluted share and Adjusted Net Operating Loss of $22.2 million -- $0.73 per diluted share 72% growth in Core (Non-Commercial Auto) Excess and Surplus Lines ("E&S") Gross Written …
SAN DIEGO, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today that it will host an investor conference call on Tuesday, November 12, 2019 at 2:00 pm Pacific Time to discuss its financial …
GAAP EPS of $1.23 per share and record non-GAAP Economic EPS of $1.64 per share Encore global revenues up 6% to a record $356 million MCM (United States) portfolio purchases up 41% to $173 million and on track for record in 2019 SAN DIEGO, Nov. 06, 2019 ( …
BETHLEHEM, Pa., Nov. 06, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its financial results for the three and nine months ended September 30, …
Continued enrollment and dose escalation of Phase 1 trial for HPN424 and Phase 1/2a trial for HPN536, Harpoon’s lead TriTAC® product candidates in development for the treatment of prostate and ovarian and pancreatic cancers, respectively. Preclinical …
BOSTON, Nov. 06, 2019 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company developing therapeutics to extend brain health, today announced that Ernest D. Penachio has joined the company as Vice President of Manufacturing Operations and CMC. …
REDMOND, Wash., Nov. 06, 2019 (GLOBE NEWSWIRE) -- MicroVision, Inc. (NASDAQ:MVIS), a leader in innovative ultra-miniature projection display and sensing technology, today announced third quarter 2019 results. Revenue for the third quarter of 2019 was $1.2 …
CHARLESTON, S.C., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Benefitfocus, Inc. (NASDAQ: BNFT), a leading cloud-based benefits management platform and services provider, today announced its third quarter 2019 financial results. Recent highlights include: Grew net …
Third Quarter Highlights Net income of $17.4 million; Return on average assets (ROAA) of 2.18%; return on average stockholders' equity (ROAE) of 20.00%; and return on average tangible common equity (ROATCE)(1) of 21.76% C Corp equivalent net income of …
ENGLEWOOD Colo., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Evolving Systems, Inc. (NASDAQ: EVOL), a leader in real-time digital engagement solutions and services for connected mobile devices, today confirmed that it will release its 2019 third quarter financial …
Total Revenue of $91.6 million, compared to $85.6 million in the third quarter of 2018 Transforms Network Segmentation with the release of Forescout eyeSegment SAN JOSE, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Forescout Technologies, Inc. (NASDAQ:FSCT), …
22% Revenue Increase Year-to-Date Update on Announced Agreement to Combine Business with Curetis Conference call to be held at 4:30 p.m. Eastern Time today GAITHERSBURG, Md., Nov. 06, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today reported …
– Recent Partnerships Support the Broad Applicability of Suprachoroidal Space Injection Platform to Potentially Treat Multiple Ocular Diseases – – Suprachoroidal Axitinib IND Submission Targeted for Mid-2020 – – Management to Host Webcast and Conference …
CLEVELAND, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended September 30, 2019. Highlights of the third quarter of 2019 and recent events include: Steady advancement of both …
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that Tassos Gianakakos, Chief Executive Officer, will participate in a fireside chat at the Credit Suisse 28th Annual Healthcare Conference on …
Net Investment Income (Loss) Improved Year Over Year by 62.5% on a per Share Basis in the Third Quarter of 2019 Adjusted Net Investment Income Increased 26.0% Year Over Year on a per Share Basis in the Third Quarter of 2019 LAKE SUCCESS, N.Y. , Nov. 06, …
Additional data from the ongoing Phase 1b portion of the MISSION study to be presented at the 2019 ACR/ARP Meeting in Atlanta, GA Phase 2 MISSION, PRESIDIO, and MARINA trials with KZR-616 are progressing KZR-261 nominated as the first oncology clinical …
